Literature DB >> 10640139

Radiation-associated sarcomas are characterized by complex karyotypes with frequent rearrangements of chromosome arm 3p.

F Mertens1, M Larramendy, A Gustavsson, D Gisselsson, A Rydholm, O Brosjö, F Mitelman, S Knuutila, N Mandahl.   

Abstract

Ionizing radiation is a well-known risk factor for sarcoma development. To investigate whether radiation-associated sarcomas are characterized by chromosome aberrations that distinguish them from de novo sarcomas, we identified those patients in our series of more than 500 cytogenetically abnormal sarcomas that fulfilled the following criteria: (1) each patient should have been irradiated for another malignancy at least 3 years prior to the sarcoma diagnosis, and (2) the sarcoma should have developed within the field of radiation. Ten patients fulfilling these criteria could be retrieved (median age at sarcoma diagnosis was 55 years, range 17-79; median latency period between primary tumor and radiation-associated sarcoma was 9 years, range 4-30). The diagnoses were typical for radiation-associated sarcomas: 2 each of malignant fibrous histiocytoma, leiomyosarcoma, and pleomorphic sarcoma, and 1 each of osteosarcoma, fibrosarcoma, myxofibrosarcoma, and spindle cell sarcoma. All 10 cases had relatively complex karyotypes with multiple, mostly unbalanced, structural rearrangements, similar to what has been reported in de novo sarcomas of the corresponding histologic subtypes. The only cytogenetic features that were unusually frequent among the radiation-associated sarcomas were the finding of unrelated clones in 3 cases, and loss of material from chromosome arm 3p, in particular 3p21-3pter, in 8 cases. Loss of the same chromosome segment has been described in 4 of the 8 previously published cases of radiation-associated sarcomas that have been analyzed after short-term culturing, which makes this imbalance significantly (P < 0.001) more frequent among radiation-associated sarcomas (12 of 18 cases) than among unselected cases of the corresponding histologic subtypes (74 of 282 cases). In contrast to the cytogenetic results, no 3p deletions were detected among the 6 cases of the present series that could be analyzed by comparative genomic hybridization (CGH). The most frequent imbalance detected by CGH was gain of 15cen-q15 (3 cases), followed by loss of chromosome 13 and gain of 5p, and 7cen-q22, each detected in 2 cases.

Entities:  

Mesh:

Year:  2000        PMID: 10640139     DOI: 10.1016/s0165-4608(99)00105-3

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  8 in total

Review 1.  Soft tissue sarcomas with complex genomic profiles.

Authors:  Louis Guillou; Alain Aurias
Journal:  Virchows Arch       Date:  2010-02       Impact factor: 4.064

Review 2.  Radiation-induced sarcomas of the head and neck.

Authors:  Anuradha Thiagarajan; N Gopalakrishna Iyer
Journal:  World J Clin Oncol       Date:  2014-12-10

3.  MYC high level gene amplification is a distinctive feature of angiosarcomas after irradiation or chronic lymphedema.

Authors:  Johanna Manner; Bernhard Radlwimmer; Peter Hohenberger; Katharina Mössinger; Stefan Küffer; Christian Sauer; Djeda Belharazem; Andreas Zettl; Jean-Michel Coindre; Christian Hallermann; Jörg Thomas Hartmann; Detlef Katenkamp; Kathrin Katenkamp; Patrick Schöffski; Raf Sciot; Agnieszka Wozniak; Peter Lichter; Alexander Marx; Philipp Ströbel
Journal:  Am J Pathol       Date:  2009-12-11       Impact factor: 4.307

4.  Radiation-associated sarcoma of the skull base after irradiation for pituitary adenoma.

Authors:  Cara L Sedney; Jonathan M Morris; Caterina Giannini; Michael J Link; Keith M Swetz
Journal:  Rare Tumors       Date:  2012-01-30

5.  Genetic features of metachronous esophageal cancer developed in Hodgkin's lymphoma or breast cancer long-term survivors: an exploratory study.

Authors:  Elisa Boldrin; Enrica Rumiato; Matteo Fassan; Rocco Cappellesso; Massimo Rugge; Vanna Chiarion-Sileni; Alberto Ruol; Rita Alfieri; Matteo Cagol; Carlo Castoro; Alberto Amadori; Daniela Saggioro
Journal:  PLoS One       Date:  2015-01-22       Impact factor: 3.240

6.  Sarcoma risk after radiation exposure.

Authors:  Amy Berrington de Gonzalez; Alina Kutsenko; Preetha Rajaraman
Journal:  Clin Sarcoma Res       Date:  2012-10-04

7.  Radiation-induced leiomyosarcoma: does antimetabolite chemotherapy contribute? A report of three cases.

Authors:  Bruce Brockstein; Arno Mundt; Daniel J Haraf; Mark Ferguson; Anthony Montag
Journal:  Sarcoma       Date:  2003

8.  Secondary uterine carcinosarcoma after concurrent chemoradiotherapy for cervical cancer: Case reports.

Authors:  Akihiko Wakayama; Wataru Kudaka; Tadaharu Nakasone; Yusuke Taira; Yoichi Aoki
Journal:  Gynecol Oncol Rep       Date:  2017-07-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.